John P. Bilbrey's Insider Trades & SAST Disclosures
John P. Bilbrey's most recent trade in Colgate-Palmolive Co. was a trade of 2,272 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John P. Bilbrey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,272 | 2,272 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,019 | 35,768 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 91.99 per share. | 01 Apr 2025 | 231 | 33,688 (0%) | 0% | 92.0 | 21,250 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 93.18 per share. | 02 Jan 2025 | 228 | 33,273 (0%) | 0% | 93.2 | 21,245 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 18,169 | 78,400 (0%) | 0% | 0 | Common Stock | |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 15 Nov 2024 | 51,697 | 318,418 | - | 1.8 | 90,470 | Common Stock |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 15 Nov 2024 | 25,128 | 266,721 | - | 1.8 | 44,225 | Common Stock |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 57.82 per share. | 14 Nov 2024 | 3,459 | 47,846 (0%) | 0% | 57.8 | 199,999 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 105.24 per share. | 01 Oct 2024 | 201 | 32,879 (0%) | 0% | 105.2 | 21,153 | Common Stock |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 19 Aug 2024 | 183,493 | 241,593 | - | 2.1 | 376,161 | Common Stock |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 203,046 | 345,903 | - | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 95.61 per share. | 01 Jul 2024 | 222 | 32,521 (0%) | 0% | 95.6 | 21,225 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 2,201 | 2,201 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,905 | 32,198 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.04 per share. | 01 May 2024 | 6,329 | 36,565 (0%) | 0% | 62.0 | 392,651 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 6,329 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Sale of securities on an exchange or to another person at price $ 91.59 per share. | 01 May 2024 | 6,329 | 30,236 (0%) | 0% | 91.6 | 579,696 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 88.36 per share. | 01 Apr 2024 | 240 | 30,236 (0%) | 0% | 88.4 | 21,206 | Common Stock |
| Colgate-Palmolive Co. | John Bilbrey P. | Director | Grant, award, or other acquisition of securities at price $ 78.18 per share. | 02 Jan 2024 | 271 | 29,829 (0%) | 0% | 78.2 | 21,187 | Common Stock |
| Elanco Animal Health Inc | John Bilbrey P. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,374 | 60,231 (0%) | 0% | 0 | Common Stock | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 10,302 | 10,302 | - | - | Stock Option | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 27.33 per share. | 02 Nov 2023 | 3,110 | 44,282 (0%) | 0% | 27.3 | 84,996 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 72.76 per share. | 02 Oct 2023 | 292 | 29,375 (0%) | 0% | 72.8 | 21,246 | Common Stock |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 1,642 | 22,065 | - | - | Phantom Stock | |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 14 Aug 2023 | 43,500 | 50,000 | - | 2.6 | 114,405 | Common Stock |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 14 Aug 2023 | 6,500 | 6,500 | - | 2.7 | 17,225 | Common Stock |
| Olaplex Holdings Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 142,857 | 142,857 | - | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 76.32 per share. | 03 Jul 2023 | 278 | 28,907 (0%) | 0% | 76.3 | 21,217 | Common Stock |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 1,489 | 20,259 | - | - | Phantom Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,884 | 2,884 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,220 | 28,628 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Sale of securities on an exchange or to another person at price $ 80.81 per share. | 09 May 2023 | 5,703 | 26,257 (0%) | 0% | 80.8 | 460,869 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 5,703 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.65 per share. | 09 May 2023 | 5,703 | 31,960 (0%) | 0% | 71.7 | 408,620 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 72.95 per share. | 03 Apr 2023 | 291 | 26,257 (0%) | 0% | 72.9 | 21,228 | Common Stock |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 1,245 | 18,643 | - | - | Phantom Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 78.40 per share. | 03 Jan 2023 | 271 | 25,809 (0%) | 0% | 78.4 | 21,246 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 722 | 14,487 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 1,161 | 17,275 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 18,649 | 39,857 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 686 | 13,764 | - | - | Deferred Stock Units | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 6,822 | 6,822 | - | - | Stock Option | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 34.98 per share. | 15 Nov 2022 | 2,430 | 41,088 (0%) | 0% | 35.0 | 85,001 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 13.24 per share. | 11 Nov 2022 | 7,500 | 41,722 (0%) | 0% | 13.2 | 99,267 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 669 | 13,078 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 75.71 per share. | 03 Oct 2022 | 280 | 25,384 (0%) | 0% | 75.7 | 21,199 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 711 | 12,408 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 1,401 | 16,001 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 583 | 11,696 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 436 | 11,112 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 77.62 per share. | 01 Jul 2022 | 273 | 24,963 (0%) | 0% | 77.6 | 21,190 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 449 | 10,676 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 1,361 | 14,492 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 372 | 10,226 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Purchase of securities on an exchange or from another person at price $ 22.03 per share. | 11 May 2022 | 10,000 | 34,222 (0%) | 0% | 22.0 | 220,284 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,122 | 3,122 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 2,317 | 24,565 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 349 | 9,854 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 75.16 per share. | 01 Apr 2022 | 283 | 22,248 (0%) | 0% | 75.2 | 21,270 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 338 | 9,505 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 1,493 | 13,028 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 310 | 9,166 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 5,389 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.76 per share. | 14 Feb 2022 | 5,389 | 26,766 (0%) | 0% | 71.8 | 386,715 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Sale of securities on an exchange or to another person at price $ 78.66 per share. | 14 Feb 2022 | 4,917 | 21,849 (0%) | 0% | 78.7 | 386,773 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 339 | 8,855 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 81.13 per share. | 03 Jan 2022 | 262 | 21,377 (0%) | 0% | 81.1 | 21,256 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 311 | 8,516 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 1,524 | 11,438 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,307 | 21,208 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 307 | 8,205 | - | - | Deferred Stock Units | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2021 | 5,523 | 5,523 | - | - | Stock Option | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 41.82 per share. | 03 Nov 2021 | 1,793 | 38,603 (0%) | 0% | 41.8 | 74,983 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 217 | 7,897 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 76.91 per share. | 01 Oct 2021 | 276 | 20,997 (0%) | 0% | 76.9 | 21,227 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 224 | 7,679 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 1,537 | 9,824 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 214 | 7,455 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 196 | 7,240 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 82.33 per share. | 01 Jul 2021 | 258 | 20,610 (0%) | 0% | 82.3 | 21,241 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 206 | 7,043 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 1,443 | 8,217 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 199 | 6,837 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 3,611 | 3,611 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 2,159 | 20,245 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.83 per share. | 05 May 2021 | 4,652 | 22,027 (0%) | 0% | 67.8 | 315,545 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 4,652 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Sale of securities on an exchange or to another person at price $ 80.95 per share. | 05 May 2021 | 3,941 | 18,086 (0%) | 0% | 81.0 | 319,024 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 226 | 6,638 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 76.48 per share. | 01 Apr 2021 | 228 | 17,375 (0%) | 0% | 76.5 | 17,437 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 243 | 6,412 | - | - | Deferred Stock Units | |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 1,282 | 6,722 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 246 | 5,950 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 218 | 6,168 | - | - | Deferred Stock Units | |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 85.10 per share. | 04 Jan 2021 | 205 | 17,051 (0%) | 0% | 85.1 | 17,446 | Common Stock |
| Elanco Animal Health Inc | John P. Bilbrey | Director | 31 Dec 2020 | 233 | 5,703 | - | - | Deferred Stock Units | ||
| Elanco Animal Health Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 5,885 | 13,901 (0%) | 0% | 0 | Common Stock | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 7,282 | 7,282 | - | - | Stock Option | |
| Tapestry Inc | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 24.71 per share. | 05 Nov 2020 | 3,035 | 36,791 (0%) | 0% | 24.7 | 74,995 | Common Stock |
| Colgate-Palmolive Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 76.68 per share. | 01 Oct 2020 | 228 | 16,757 (0%) | 0% | 76.7 | 17,483 | Common Stock |
| Campbell Soup Co. | John P. Bilbrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 1,332 | 4,036 | - | - | Phantom Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges